Publicaciones en las que colabora con JESÚS FERNANDO SAN MIGUEL IZQUIERDO (21)

2019

  1. Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy

    Blood

2017

  1. Differentiation stage of myeloma plasma cells: Biological and clinical significance

    Leukemia, Vol. 31, Núm. 2, pp. 382-392

  2. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

    Leukemia, Vol. 31, Núm. 10, pp. 2094-2103

2016

  1. Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients

    Blood, Vol. 127, Núm. 25, pp. 3165-3174

2014

  1. Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations

    Leukemia

2007

  1. Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma

    Blood, Vol. 110, Núm. 9, pp. 3112-3121

2006

  1. TCRγδ+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRγδ+ T-cells

    Leukemia, Vol. 20, Núm. 3, pp. 505-513

2003

  1. Clonality analysis for antigen receptor genes: Preliminary results from the biomed-2 concerted action PL 96-3936

    Human Pathology

  2. Clonality analysis for antigen receptors genes - Results from the biomed-2 concerted action PL 96-3936

    UPDATE IN PATHOLOGY, PROCEEDINGS

  3. Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: Immunobiological characteristics and clinical implications

    Leukemia, Vol. 17, Núm. 7, pp. 1398-1403

2001

  1. BIOMED-I concerted action report: Flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

    Leukemia, Vol. 15, Núm. 8, pp. 1185-1192

  2. Immunoglobulin lambda isotype, gene rearrangements in B cell malignancies

    Leukemia, Vol. 15, Núm. 1, pp. 121-127

  3. Minimal residual disease in leukaemia patients

    Lancet Oncology, Vol. 2, Núm. 7, pp. 409-417

2000

  1. BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

    Leukemia, Vol. 14, Núm. 5, pp. 816-825

1999

  1. Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL

    British Journal of Haematology, Vol. 104, Núm. 4, pp. 695-705

  2. Flow cytometric analysis of normal B cell differentiation: A frame of reference for the detection of minimal residual disease in precursor-B-ALL

    Leukemia, Vol. 13, Núm. 3, pp. 419-427

  3. Heteroduplex PCR analysis of rearranged immunoglobulin genes for clonality assessment in multiple myeloma

    Haematologica, Vol. 84, Núm. 4, pp. 328-335

  4. Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma. A comparison between different strategies

    Haematologica, Vol. 84, Núm. 9, pp. 779-784

  5. Immunophenotypical detection of minimal residual disease in acute leukemia

    Critical Reviews in Oncology/Hematology, Vol. 32, Núm. 3, pp. 175-185

  6. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets. Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemia

    Leukemia, Vol. 13, Núm. 1, pp. 110-118